European Commission (EC) Extends the Approval of Evkeeza® – GlobeNewswire
Evkeeza, an angiopoietin-like 3 (ANGPTL3) inhibitor, is the first medicine indicated for children in the European Union (EU) as young as 6-months old …Read More
The Heartbeat of World events
Evkeeza, an angiopoietin-like 3 (ANGPTL3) inhibitor, is the first medicine indicated for children in the European Union (EU) as young as 6-months old …Read More
